The Forum on Neuroscience and Nervous System Disorders hosted a public session at the 2011 Alzheimer's Association International Conference to identify a set of core principles that could be used to ...

Traditional approaches for detecting Alzheimer’s disease (AD) that rely on examining the brain for amyloid plaques have limitations in accuracy and early detection. Although the industry has ...

Mayo Clinic researchers validated an FDA-approved blood test that diagnoses Alzheimer’s disease with 95% sensitivity and 82% specificity in outpatient settings. The test offers a less invasive and ...

Alzheimer’s blood test breakthrough: 34 circular RNA biomarkers validated in nearly 2,400 patients outperform the pTau217 ...

The Davos Alzheimer’s Collaborative (DAC), a pioneering worldwide initiative seeking to cure Alzheimer’s disease and improve brain health, today announced they will work with Janssen Research & ...

A new wave of blood tests aiming to predict Alzheimer’s risk may offer hope for earlier detection — but they could also raise concerns about the accuracy and reliability of the results. A recent study ...

The ADAPT study validates plasma p-tau217 assays against CSF standards, outlining optimal dual cut-points for clinical ...

Data Across 29 Presentations Highlights Precision, Accessibility and Platform-Agnostic Adoption, Establishing ALZpath's Proprietary pTau217 as a Highly Accurate Industry Benchmark CARLSBAD, Calif., ...

A charity has had to employ additional chaplains to help residents cope with the trauma of homelessness in Dublin ...